| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Homo sapiens
|
Jianxin Wang
|
Aug 26, 2024
|
|||||
| GSE275628 |
TAS-102, Irinotecan, and Bevacizumab in Pre-treated Metastatic Colorectal Cancer (TABAsCO), A Phase II Clinical Trial. ClinicalTrials.gov NCT04109924
|
|
34 | Jianxin Wang | Aug 26, 2024 |
